Scarica l'app Stockscreener
40.73
14.72%
-7.03
Precedente Chiudi:
$47.76
Aprire:
$49
Volume 24 ore:
2.84M
Relative Volume:
2.27
Capitalizzazione di mercato:
$1.37B
Reddito:
$117.67M
Utile/perdita netta:
$-1.88B
Rapporto P/E:
-0.6728
EPS:
-60.5369
Flusso di cassa netto:
$-621.36M
1 W Prestazione:
-25.97%
1M Prestazione:
+120.28%
6M Prestazione:
+140.72%
1 anno Prestazione:
+0.00%
Intervallo 1D:
$37.85
$49.00
Intervallo di 1 settimana:
$37.85
$63.99
Portata 52W:
$12.33
$63.99
Grail Inc Stock (GRAL) Company Profile
Nome
Grail Inc
Settore
Industria
Telefono
650-771-9796
Indirizzo
1525 O'BRIEN DRIVE, MENLO PARK
Confronta GRAL con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
GRAL
Grail Inc
|
40.73 | 1.37B | 117.67M | -1.88B | -621.36M | -60.54 |
|
TMO
Thermo Fisher Scientific Inc
|
532.55 | 203.70B | 42.88B | 6.34B | 7.27B | 16.53 |
|
DHR
Danaher Corp
|
210.23 | 151.18B | 23.88B | 3.90B | 5.30B | 5.28 |
|
A
Agilent Technologies Inc
|
135.37 | 38.62B | 6.51B | 1.29B | 1.37B | 4.42 |
|
IDXX
Idexx Laboratories Inc
|
452.77 | 37.07B | 3.90B | 887.87M | 808.08M | 10.67 |
|
IQV
Iqvia Holdings Inc
|
191.04 | 33.64B | 15.41B | 1.37B | 2.11B | 7.50 |
Grail Inc Stock (GRAL) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-11-27 | Iniziato | Morgan Stanley | Equal-Weight |
| 2024-11-15 | Iniziato | Wolfe Research | Peer Perform |
| 2024-10-17 | Iniziato | Guggenheim | Neutral |
Grail Inc Borsa (GRAL) Ultime notizie
Why Grail (GRAL) Is Falling Today - MSN
GRAIL to Present at TD Cowen 45th Annual Health Care Conference - WV News
Grail projects FDA submission completion for Galleri by H1 2026 with expanded scalability - MSN
GRAIL Q4 Loss Narrows, Revenue Up; Shares Rise After-Hours -February 20, 2025 at 05:36 pm EST - Marketscreener.com
Earnings call transcript: Grail's Q4 2024 revenue rises, stock surges - Investing.com
Earnings call transcript: Grail’s Q4 2024 revenue rises, stock surges By Investing.com - Investing.com Nigeria
Grail reports Q4 EPS ($2.89) vs. ($6.04) last year - TipRanks
Earnings call transcript: Grail's Q4 2024 revenue rises, stock surges By Investing.com - Investing.com UK
GRAIL Reports Fourth Quarter and Full Year 2024 Financial Results - TradingView
Earnings Flash (GRAL) GRAIL INC. Posts Q4 Revenue $38.3M, vs. FactSet Est of $34.4M - Marketscreener.com
Can GRAIL's 137,000 Cancer Test Sales Overcome Its $2B Loss? Key Earnings Insights - StockTitan
Grail Inc options imply 13.5% move in share price post-earnings - TipRanks
Investors Eye Biotech Sector as Cancer Therapy Market Surges - The Malaysian Reserve
We're Keeping An Eye On GRAIL's (NASDAQ:GRAL) Cash Burn Rate - Yahoo Finance
Grail Inc expected to post a loss of $7.05 a shareEarnings Preview - TradingView
Grail rallies 30% in wake of Quest agreement - MSN
Grail (NASDAQ:GRAL) Trading 5.4% HigherWhat's Next? - MarketBeat
Moloney Securities Asset Management LLC Invests $559,000 in Grail, Inc. (NASDAQ:GRAL) - MarketBeat
Grail shares jump on partnership with Quest Diagnostics - Mugglehead
GRAIL teams up with Quest to widen access to Galleri cancer test - MSN
C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors Makes New $244,000 Investment in Grail, Inc. (NASDAQ:GRAL) - MarketBeat
abrdn plc Purchases Shares of 211,068 Grail, Inc. (NASDAQ:GRAL) - MarketBeat
Grail rallies 30% in wake of Quest agreement (GRAL:NASDAQ) - Seeking Alpha
Grail distribution partnership with Quest a positive, says Guggenheim - TipRanks
Grail and Quest Diagnostics to offer Galleri test to US physicians - Yahoo
Grail (NASDAQ:GRAL) Reaches New 12-Month HighWhat's Next? - MarketBeat
Grail (GRAL) to Release Earnings on Tuesday - MarketBeat
Early Cancer Detection Pioneer GRAIL Sets Crucial Q4 Earnings Release Date - StockTitan
Grail Shares Spiked Wednesday: What's Going On? - Benzinga
Grail and Quest Diagnostics announces initial phase of MCED test program - TipRanks
Why Grail (GRAL) Stock Is Jumping Today - Insider Monkey
GRAIL joins Quest to widen Galleri access (GRAL:NASDAQ) - Seeking Alpha
Grail Makes Cancer Early Detection Test Directly Available to US Physicians Via Quest Diagnostics Collaboration - Marketscreener.com
Grail And Quest Diagnostics Provide Grail's Galleri Multi-Cancer Early Detection (MCED) Test - Marketscreener.com
Revolutionary Cancer Detection Test Now Available at Quest Labs NationwideEarly Detection for 50+ Types - StockTitan
Grail (NASDAQ:GRAL) Sets New 52-Week HighShould You Buy? - MarketBeat
HOLY GRAIL OF MEMPHIS Extended Again At Arden Theatre Company - BroadwayWorld
Grail (NASDAQ:GRAL) Trading 6.1% HigherStill a Buy? - MarketBeat
Perigon Wealth Management LLC Makes New Investment in Grail, Inc. (NASDAQ:GRAL) - MarketBeat
Grail (NASDAQ:GRAL) Stock Price Down 6.6%What's Next? - MarketBeat
Grail, Inc. (NASDAQ:GRAL) Sees Large Increase in Short Interest - MarketBeat
Grail Inc Azioni (GRAL) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.06%
3.50%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):